Literature for C111.001
(Topics flags: S Structure, A Assay, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Desage,S., Leuci,A., Enjolras,N., Holle,L.A., Singh,S., Delavenne,X., Wolberg,A.S., Biswas,A. and Dargaud,Y.
Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit
Haemophilia29, 1483-1489. PubMed Europe PubMed DOI -
Osaki,T., Souri,M., Ozawa,T., Muraguchi,A. and Ichinose,A.
Epitope analysis of human monoclonal antibodies from a patient with autoimmune factor XIII deficiency reveals their inhibitory mechanisms
FEBS Lett597, 1275-1289. PubMed Europe PubMed DOI -
De Simone,I., Baaten,C.C.F.M., Jandrot-Perrus,M., Gibbins,J.M., ten Cate,H., Heemskerk,J.W.M., Jones,C.I. and van der Meijden,P.E.J.
Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
Int J Mol Sci23, PubMed Europe PubMed DOI -
Leitner,M., Buchold,C., Pasternack,R., Binder,N.B. and Moore,G.W.
Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity
Int J Mol Sci22, PubMed Europe PubMed DOI -
Anokhin,B.A., Dean,W.L., Smith,K.A., Flick,M.J., Ariens,R.A.S., Philippou,H. and Maurer,M.C.
Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A
FEBS J287, 452-464. PubMed Europe PubMed DOI -
Csoban-Szabo,Z., Fesus,L. and Kiraly,R.
Protein-peptide based assay for the characterization of human blood coagulation factor XIII-A isopeptidase activity
Anal Biochem113699-113699. PubMed Europe PubMed DOI A -
Leitner,M., Buchold,C., Pasternack,R. and Binder,N.B.
Feasibility of an automated coagulation factor XIIIa test using its isopeptidase activity
Anal Biochem113757-113757. PubMed Europe PubMed DOI A -
Pasternack,R., Buchold,C., Jahnig,R., Pelzer,C., Sommer,M., Heil,A., Florian,P., Nowak,G., Gerlach,U. and Hils,M.
Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)
J Thromb Haemost18, 191-200. PubMed Europe PubMed DOI -
Pedersen,N.B., Stolberg,C.R., Mundbjerg,L.H., Juhl,C.B., Gram,B., Funch-Jensen,P., de Maat,M.P.M., Munster,A.B. and Bladbjerg,E.M.
Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6 months after obesity surgery
Clin Obese12397-e12397. PubMed Europe PubMed DOI -
Schmitz,T., Bauml,C.A. and Imhof,D.
Inhibitors of blood coagulation factor XIIIa
Anal Biochem113708-113708. PubMed Europe PubMed DOI I -
Anokhin,B.A., Stribinskis,V., Dean,W.L. and Maurer,M.C.
Activation of factor XIII is accompanied by a change in oligomerization state
FEBS J284, 3849-3861. PubMed Europe PubMed DOI -
Shubin,N.J., Glukhova,V.A., Clauson,M., Truong,P., Abrink,M., Pejler,G., White,N.J., Deutsch,G.H., Reeves,S.R., Vaisar,T., James,R.G. and Piliponsky,A.M.
Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation
J Allergy Clin Immunol139, 323-334. PubMed Europe PubMed DOI -
Avery,C.A., Pease,R.J., Smith,K., Boothby,M., Buckley,H.M., Grant,P.J. and Fishwick,C.W.
(+/-) cis-Bisamido epoxides: a novel series of potent FXIII-A inhibitors
Eur J Med Chem98, 49-53. PubMed Europe PubMed DOI I -
Heil,A., Weber,J., Buchold,C., Pasternack,R. and Hils,M.
Differences in the inhibition of coagulation factor XIII-A from animal species revealed by Michael acceptor- and thioimidazol based blockers
Thromb Res131, e214-e222. PubMed Europe PubMed DOI I -
Schroeder,V. and Kohler,H.P.
New developments in the area of factor XIII
J Thromb Haemost11, 234-244. PubMed Europe PubMed DOI V -
Jadhav,M.A., Lucas,R.C., Goldsberry,W.N. and Maurer,M.C.
Design of factor XIII V34X activation peptides to control ability to interact with thrombin mutants
Biochim Biophys Acta1814, 1955-1963. PubMed Europe PubMed DOI -
Fesus,L. and Piacentini,M.
Transglutaminase 2: an enigmatic enzyme with diverse functions
Trends Biochem Sci27, 534-539. PubMed Europe PubMed DOI -
Makarova,K.S., Aravind,L. and Koonin,E.V.
A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases
Protein Sci8, 1714-1719. PubMed Europe PubMed DOI -
[YEAR:15-5-1998]Jenner,L., Husted,L., Thirup,S., Sottrup-Jensen,L. and Nyborg,J.
Crystal structure of the receptor-binding domain of alpha2-macroglobulin
Structure6, 595-604. PubMed Europe PubMed S -
Pedersen,L.C., Yee,V.C., Bishop,P.D., Le Trong,I., Teller,D.C. and Stenkamp,R.E.
Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules
Protein Sci3, 1131-1135. PubMed Europe PubMed DOI S -
Lorand,L., Jeong,J.M., Radek,J.T. and Wilson,J.
Human plasma factor XIII: subunit interactions and activation of zymogen
Methods Enzymol222, 22-35. PubMed Europe PubMed DOI -
Ichinose,A., Bottenus,R.E. and Davie,E.W.
Structure of transglutaminases
J Biol Chem265, 13411-13414. PubMed Europe PubMed V -
[YEAR:16-6-1988]Lynch,G.W. and Pfueller,S.L.
Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease
Thromb Haemost59, 372-377. PubMed Europe PubMed -
Takahashi,N., Takahashi,Y. and Putnam,F.W.
Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta
Proc Natl Acad Sci U S A83, 8019-8023. PubMed Europe PubMed -
[YEAR:21-3-1983]Ichinose,A., Tamaki,T. and Aoki,N.
Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin
FEBS Lett153, 369-371. PubMed Europe PubMed DOI -
[YEAR:25-12-1982]Tamaki,T. and Aoki,N.
Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor
J Biol Chem257, 14767-14772. PubMed Europe PubMed -
Mortensen,S.B., Sottrup-Jensen,L., Hansen,H.F., Rider,D., Petersen,T.E. and Magnusson,S.
Sequence location of a putative transglutaminase crosslinking site in human alpha2-macroglobulin
FEBS Lett129, 314-317. PubMed Europe PubMed
2023
2022
2021
2020
2017
2015
2013
2011
2002
1999
1998
1994
1993
1990
1988
1986
1983
1982
1981
